Telemedicine in the Time of Coronavirus

Calton, Brook; Abedini, Nauzley C.; Fratkin, Michael D.

doi:10.1016/j.jpainsymman.2020.03.019

Cited by 394 publications

(382 citation statements)

References 1 publication

Supporting

Mentioning

345

Contrasting

Unclassified

Order By: Relevance

“…Although less than ideal, we are fortunate that technology-mediated conversation has proved an adequate substitute for in-person GOC discussion when needed. 10 This is not a new concept, as involving family and loved ones by phone or video has been in use before the current pandemic, although at a much lower frequency. In our case Mr. V was able to use video technology to include his girlfriend in a GOC discussion with the medical staff in a more meaningful and interactive way than a phone call alone.…”

Section: Barriers To Communicationmentioning

confidence: 99%

Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life

Pahuja

Wojcikewych

2021

Journal of Palliative Medicine

View full text Add to dashboard Cite

The Novel Coronavirus SARS-CoV-2 (COVID-19) pandemic is changing how we deliver expert palliative care. We can expect many to die prematurely secondary to COVID-19 across the United States. We present a case of how several hospital systems-based interventions, intended to slow viral spread and to protect health care workers, have inadvertently created barriers to routine palliative interventions in this patient population. Isolation of patients, limitation of visitors and interdisciplinary support, and changes in nursing and provider assessment have all had their impact on how we deliver palliative care. These barriers have altered many aspects of our established workflow and algorithms for care, including changes in communication, goals of care discussions, how providers and nurses are monitoring for symptoms, and end-of-life monitoring. These challenges required real-time solutions such as technology utilization, proposing a change in medical delivery systems, and reducing redundancy to preserve personal protective equipment. To continue to deliver quality care for this patient population, palliative medicine must adapt quickly.We present a case that illustrates how safety precautions implemented for COVID-19 have created unique barriers to assessing and treating symptoms in this patient population at the end of life and changes made within our system to overcome these barriers.

show abstract

Section: Barriers To Communicationmentioning

confidence: 99%

Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life

Pahuja

Wojcikewych

2021

Journal of Palliative Medicine

View full text Add to dashboard Cite

show abstract

“…Telemedicine has been implemented worldwide in response of COVID-19 pandemic to bring medical care to patients while attempting to reduce the transmission of SARS-CoV-2 to patients, families, and healthcare staff (5)(6)(7).…”

Section: Introductionmentioning

confidence: 99%

Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context

Daruich

Martin²,

Bremond-Gignac

2020

Journal Français d'Ophtalmologie

View full text Add to dashboard Cite

Nous rapportons le cas d'un homme de 27 ans qui a consulté par télémédecine lors de la pandémie de Coronavirus Disease 2019 (COVID-19), pour une sensation de corps étranger et une rougeur à l'oeil gauche. L'examen a révélé un oedème palpébral unilatéral et une hyperémie conjonctivale diffuse modérée. Quelques heures plus tard, le patient a présenté des céphalées intenses, de la fièvre, de la toux et une dyspnée sévère, et une PCR nasopharyngée est revenue positive au SARS-CoV-2, posant le diagnostic de COVID-19. Ce cas démontre la possibilité d'une conjonctivite inaugurale lors de l'infection COVID-19. Il illustre l'intérêt de la télémédecine en ophtalmologie lors de la pandémie, une hyperémie conjonctivale modérée pouvant être le premier signe d'une détresse respiratoire sévère. Abstract We report here the case of a 27-year-old man who consulted by telemedicine during the Coronavirus Disease 2019 (COVID-19) pandemic, due to foreign body sensation and left eye redness. Examination revealed unilateral eyelid edema and moderate conjunctival hyperemia. A few hours later the patient experienced intense headache and developed fever, cough and severe dyspnea. A nasopharyngeal swab proved positive for SARS-CoV-2. This case demonstrates that conjunctivitis can be the inaugural manifestation of the COVID-19 infection. It illustrates the interest of telemedicine in ophthalmology during the COVID-19 pandemic, since moderate conjunctival hyperemia can be the first sign of a severe respiratory distress. Page 4 of 7 J o u r n a l P r e -p r o o f Legend Figure 1: Smartphone photograph of a left eye conjunctivitis as first presentation of Coronavirus Disease 2019 during teleophthalmology consultation. A. Left eyelid edema. B. Moderate temporal conjunctival hyperemia of the left eye. C. Inferior bulbar conjunctival hyperemia of the left eye.

show abstract

“…En general, el estudio muestra que la opinión de los encuestados prevé pocos cambios en el futuro a medio plazo, estos serán más en los hábitos de prevención y en la circulación de personas, reduciéndose la presencia numerosa en salas de esperas, sesiones docentes o pases de visita. Existe un convencimiento mayoritario que la pandemia conllevará a un mayor uso de los recursos de telemedicina (23,24,25,26,27) y la virtualización de la docencia. También existe consenso en que deberá haber una reorganización de los tiempos de asistencia y búsqueda de métodos alternativos para evitar la presencia excesiva de enfermos y especialmente los neurológicos, ya que son especialmente vulnerables.…”

Section: Discussionunclassified

¿Va a cambiar la neurología tras la pandemia de COVID-19 en los próximos 5 años? Estudio de enfoque mediante informadores clave

et al. 2020

View full text Add to dashboard Cite

show abstract

Telemedicine in the Time of Coronavirus

Cited by 394 publications

References 1 publication

Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life

Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life

Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context

¿Va a cambiar la neurología tras la pandemia de COVID-19 en los próximos 5 años? Estudio de enfoque mediante informadores clave

Contact Info

Product

Resources

About